Suicide rates amongst individuals from ethnic minority backgrounds: A systematic review and meta-analysis

Troya, M. Isabela; Spittal, Matthew J; Pendrous, Rosina; Crowley, Grace; Gorton, Hayley C.; Russell, Kirsten; Byrne, Sadhbh; Musgrove, Rebecca; Hannam-Swain, Stephanie; Kapur, Navneet; Knipe, Duleeka

doi:10.1016/j.eclinm.2022.101399

Cited by 24 publications

(12 citation statements)

References 154 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Racial groups may differ in suicide rates, but racial minorities and marginalized racial groups appear to be at high risk. Research findings report a higher suicide risk among migrants of ethnic minorities in Europe ( Forte et al, 2018 ), indigenous groups in Oceania ( Dickson et al, 2019 ; Hatcher, 2016 ) and South America ( Troya et al, 2022 ), and increasing suicide rates for Blacks and Native Americans in the U.S ( Lindsey et al, 2019 ; Shain, 2019 ). Notably, increasing rates of suicide among young individuals from minority groups have also been observed across different societies ( Dickson et al, 2019 ; Forte et al, 2018 ), elevating suicide as the second leading cause of death among Native American youth and the third among African American youth ( Heron, 2016 ; Shaughnessy et al, 2004 ).…”

Section: Introductionmentioning

confidence: 99%

Meta-analysis of the effect of racial discrimination on suicidality

Coimbra

Hoeboer²,

Yik³

et al. 2022

SSM - Population Health

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Meta-analysis of the effect of racial discrimination on suicidality

Coimbra

Hoeboer²,

Yik³

et al. 2022

SSM - Population Health

View full text Add to dashboard Cite

“…Further work would be needed to address representation of the wider clinical population especially from ethnically diverse backgrounds. This element will be crucial to address given that a recent combined systematic review and meta-analysis has highlighted the importance of addressing the differences of suicide risk in groups from ethnic minority backgrounds 30…”

Section: Discussionmentioning

confidence: 99%

Suicidality Treatment Occurring in Paediatrics (STOP) Medication Suicidality Side Effects Scale in young people in two cohorts across Europe

Santosh,

Sala,

Lievesley

et al. 2023

BMJ Open

View full text Add to dashboard Cite

ObjectivesAs part of the ‘Suicidality: Treatment Occurring in Paediatrics (STOP)’ study, we developed and performed psychometric validation of an electronic-clinical-outcome-assessment (eCOA), which included a patient-reported-outcome (ePRO), an observer-rated-outcome (eObsRO) for parents/carers and a clinician-reported-outcome (eClinRO) that allows identification and monitoring of medication-related suicidality (MRS) in adolescents.DesignSTOP: Prospective study: A two phase validation study to assess the impact of medication on suicidal ideations.SettingSix participating countries: Netherlands, UK, Germany, France, Spain and Italy that were part of the Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 261411.ParticipantsCohort 1 consisted of 41 adolescent-completions, 50 parent-completions and 56 clinician-completions. Cohort 2 consisted of 244 adolescent-completions, 198 parent-completions and 240 clinician-completions from across the six countries. The scale was administered only to participants who have screened positive for the STOP-Suicidality Assessment Scale (STOP-SAS).ResultsA total of 24 items for the development of the STOP-Medication Suicidality Side Effects Scale (STOP-MS3) were identified and three versions (for patients, parents and clinicians) of the STOP-MS3were developed and validated in two separate study cohorts comprising of adolescents, their parents and clinicians. Cronbach’s α coefficients were above 0.85 for all domains. The inter-rater reliability of the STOP-MS3was good and significant for the adolescent (ePRO), clinician (eClinRO) (r=0.613), parent (eObsRO) versions of the scale (r=0.394) and parent and clinician (r=0.347). Exploratory factor analysis identified a 3-factor model across 24 items for the adolescent and parent version of the scale: (1) Emotional Dysregulation, (2) Somatic Dysregulation and (3) Behavioural Dysregulation. For the clinician version, a 4-factor model defined the scale structure: (1) Somatic Dysregulation, (2) Emotional Dysregulation, (3) Behavioural Dysregulation and (4) Mood Dysregulation.ConclusionThese findings suggest that the STOP-MS3scale, a web-based eCOA, allows identification and monitoring of MRS in the adolescent population and shows good reliability and validity.

show abstract

“…Finally, the study enrolled 80% Caucasians and therefore minority racial-ethnic groups were underrepresented, relative to the general population, which may affect the generalizability of the results. Prior work indicates that suicidality in general maybe higher in particular minority racial-ethnic groups, notably in relation to indigenous populations ( Troya et al, 2022 ), highlighting the need to study this issue in future trichotillomania research.…”

Section: Discussionmentioning

confidence: 99%